Mural Oncology plc (NASDAQ: MURA) open the trading on Wednesday, with great promise as it jumped 5.19% to $3.65, before settling in for the price of $3.47 at the close. Taking a more long-term approach, MURA posted a 52-week range of $2.87-$6.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 6.94%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 39.04%. This publicly-traded company’s shares outstanding now amounts to $17.04 million, simultaneously with a float of $15.55 million. The organization now has a market capitalization sitting at $62.27 million. At the time of writing, stock’s 50-day Moving Average stood at $3.54, while the 200-day Moving Average is $3.51.
Mural Oncology plc (MURA) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Mural Oncology plc’s current insider ownership accounts for 8.82%, in contrast to 61.79% institutional ownership. According to the most recent insider trade that took place on Dec 23 ’24, this organization’s insider sold 2,555 shares at the rate of 3.27, making the entire transaction reach 8,355 in total value, affecting insider ownership by 41,295.
Mural Oncology plc (MURA) Earnings and Revenue Records
Mural Oncology plc’s EPS increase for this current 12-month fiscal period is 39.04% and is forecasted to reach -4.94 in the upcoming year.
Mural Oncology plc (NASDAQ: MURA) Trading Performance Indicators
Let’s observe the current performance indicators for Mural Oncology plc (MURA). It’s Quick Ratio in the last reported quarter now stands at 7.38. The Stock has managed to achieve an average true range (ATR) of 0.24.
In the same vein, MURA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -9.14, a figure that is expected to reach -2.01 in the next quarter, and analysts are predicting that it will be -4.94 at the market close of one year from today.
Technical Analysis of Mural Oncology plc (MURA)
[Mural Oncology plc, MURA] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 83.44% While, its Average True Range was 0.24.
Raw Stochastic average of Mural Oncology plc (MURA) in the period of the previous 100 days is set at 56.12%, which indicates a major fall in contrast to 82.11% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 49.56% that was higher than 49.52% volatility it exhibited in the past 100-days period.
